Meningococcemia historical perspective

Revision as of 17:47, 14 November 2014 by Ammu Susheela (talk | contribs)
Jump to navigation Jump to search

Meningococcemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Meningococcemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Treatment

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Meningococcemia historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Meningococcemia historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Meningococcemia historical perspective

CDC on Meningococcemia historical perspective

Meningococcemia historical perspective in the news

Blogs on Meningococcemia historical perspective

Directions to Hospitals Treating Meningococcemia

Risk calculators and risk factors for Meningococcemia historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Overview

Historical Perspective

  • Records indicate that the first case of meningococcal meningitis was described in Geneva in 1805.[1]
  • Another case was reported in New England , New Bedford , Massachusetts in 1806.[2]
  • The causative agent was described as intracellular oval cocci in a cerebrospinal fluid sample by Marchiafava and Celli in 1884.
  • The organism was isolated by Anton Weischselbaum in 1887 and he gave the term Diplococcus intracellularis meningitidis.

References

  1. "Meningococcus".
  2. Stephens DS (2009). "Biology and pathogenesis of the evolutionarily successful, obligate human bacterium Neisseria meningitidis". Vaccine. 27 Suppl 2: B71–7. doi:10.1016/j.vaccine.2009.04.070. PMC 2712446. PMID 19477055.